NEW

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module

Activ Surgical announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s ActivSight Intraoperative Imaging Module for enhanced surgical visualization.

Metrex Surface Disinfectant Portfolio Secures EPA Approval

The U.S. Environmental Protection Agency (EPA) has approved all eight surface disinfectant products made by an infection prevention leader, Metrex, as effective against SARS-CoV-2, the novel coronavirus that causes COVID-19.

Olympus Supports Safety Actions Regarding Surgical Smoke

Olympus has announced its support of The Joint Commission’s recommended safety actions for managing the hazards of exposure to surgical smoke for health care staff in operating rooms.

Exofin Fusion Redesign Receives FDA Approval

Chemence Medical, a leader in medical cyanoacrylate devices and products, announced the U.S. Federal Drug Administration’s (FDA) 510(k) approval of the company’s redesigned exofin fusion skin closure system.

Checkpoint Surgical Adding New Jobs at Highland Hills Headquarters

Checkpoint Surgical has announced that it will add 18 new jobs at its headquarters in Highland Hills, Ohio, with the assistance of an Ohio Job Creation Tax Credit totaling $200,000. The addition of these 18 jobs comes with an associated payroll of $1.9 million; Checkpoint Surgical will also retain its current 17 employees with an associated payroll of nearly $2.3 million. The new jobs added will be in such areas as engineering, technical support, sales and marketing.

Checkpoint Surgical partners with surgeons to advance the understanding of nerve function and recovery. The company’s handheld nerve stimulation devices inform intra-operative decision-making and enable surgeons to protect, assess and restore nerves across the anatomy.

“The state’s support helps to reduce the cost of growing here in our hometown, allowing the company to keep more of our team local as opposed to other locations outside the state,” says Len Cosentino, president and CEO of Checkpoint Surgical. “This support is critical to managing the high costs associated with scaling a medical device company in a highly competitive worldwide market.”

BioEnterprise, the nonprofit accelerator that works to build Cleveland’s health care industry, collaborated with partners JobsOhio and Team NEO on this project, and was also an investor in Checkpoint Surgical through its Medical Growth Fund I.

“We are excited to see Checkpoint Surgical’s continued progress and growth in the field of neurostimulation, which is a $15 billion industry,” says Aram Nerpouni, president and CEO of BioEnterprise. “‘Their growth reflects the rich history of innovation in neurostimulation in Northeast Ohio, driven in no small part by its parent company, NDI Medical, and NDI’s other spin-outs.”

In September 2019, Checkpoint Surgical received FDA Breakthrough Device Designation for its Checkpoint brief electrostimulation therapy (BEST) device, which is designed to promote nerve regeneration in surgical procedures for nerve injury. The Breakthrough Device Designation is a process designed to expedite the development of therapies for serious conditions that show promise in making substantial improvements over what’s currently available.

“Along with JobsOhio, BioEnterprise and our local partners, we congratulate Checkpoint Surgical on its expansion and welcome the new high-paying jobs it will bring to the region,” says Team NEO CEO Bill Koehler. “Checkpoint Surgical is an example of how innovative healthcare companies are leveraging our region’s prestigious educational institutions and talented workforce to grow.”

In September 2018, Checkpoint Surgical completed an $8.8 million equity financing round led by Mutual Capital Partners, with additional participation by Chicago-based First Analysis, JumpStart NEXT Fund and several individual investors. That investment allowed the company to add new sales and marketing resources, develop new market opportunities and build out its R&D team.

“We are excited about the continued growth at Checkpoint, driven by great progress and prospects for positively impacting medical care,” says Wayne Wallace, co-founder of Mutual Capital Partners. “Watching the team advance nerve protection and repair through novel new products is rewarding. The side benefit of high-quality job creation in Northeast Ohio is awesome as MCPF continues to think globally and act locally.”

“We are pleased that Checkpoint Surgical has chosen our community as its home,” says Michael Booker, mayor of the Village of Highland Hills. “They are a company that exemplifies the Village’s vison of making people lives better.”

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X